Table 1 Description of studies excluded in review
From: Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence
N | Author/Country | Population/Study design | Reasons for exclusion |
|---|---|---|---|
1 | Shalhoub 2015 Saudi Arabia | A patient with MERS-CoV/HIV co-infection/case study | TB status was not reported |
2 | Bogorodckaya 2020 Russia | three TB patients co-infected with COVID-19/ case study | Cases were incompletely reported. |
3 | Wang 2020 China [26] | A patient with COVID-19/HIV co-infection/case report | TB status was not reported |
4 | Zhu 2020 China | A patient with COVID-19/HIV co-infection/case report | TB status was not reported |
5 | Zhao 2020 China | A patient with COVID-19/HIV/HCV co-infection/ case report | TB status was not reported |
6 | Baluku 2020 Uganda | A patient with COVID-19/HIV co-infection /case report | TB status was not reported |
7 | Blanco 2020 Spain | Five cases of COVID-19/HIV co-infection/ clinical case series | None reported TB status |
8 | Riva 2020 Italy | Three cases with COVID-19/HIV co-infection / case series | None reported TB status |
9 | Aydin 2020 Turkey | Three patients with COVID-19/HIV co-infection /case series | Outcomes of interest were not reported |
10 | Benkovic 2020 USA | Four patients with COVID-19/HIV Co-infection/Case series | Outcomes of interest were not reported |
11 | Haddad 2020 USA | A case with COVID-19/HIV co-infection/Case report | TB screening was not reported |
12 | Gervasoni 2020 Italy | 47 COVID-19/HIV co-infected patients Retrospective study | Outcomes of interest were not reported |
13 | Wang 2020 China [26] | A patient with COVID-19/HIV Co-infection/Case report | TB status was not reported |
14 | Härter 2020 Germany | 33 COVID-19/HIV co-infected patients Retrospective study | Outcomes of interest were not reported |
15 | Wu 2020 China | Two patients with COVID-19/HIV co-infection/Case series | TB screening was not reported |
16 | Del 2020 Spain [27] | 77,590 COVID/HIV co-infected cases | Outcomes of interest were not reported |
17 | Bulled 2020 South Africa | Comment on COVID-19/HIV/TB co-infection | This was a commentary |
18 | Tadolini 2020 Italy | 49 patients with COVID-19/TB co-infection | Duplicate report from the same cohort |
19 | Chen 2020 China [28] | COVID-19/TB burden | Letter to the editor without case report |
20 | Drain 2020 USA | Explanatory article on COVID/HIV burden | TB screening was not reported |
21 | Karim 2020 USA | Included percentage of COVID-19/HIV/TB report | No primary data reported |
22 | Pang 2020 China | Included COVID-19/TB cases | A correspondence |
23 | Wang 2020 China [26] | A case of COVID-19/HIV co-infection | The outcomes of interest were not reported |
24 | Kilds 2020 USA | A case of COVID-19/HIV co-infection | The outcomes of interest were not reported |
25 | Ridgway 2020 USA | A case series of five COVID-19/HIV co-infection | Had no outcome of interest reported |
26 | Sigel 2020 USA | Eighty eight COVID-19/HIV co-infection | Had no outcome of interest reported |
27 | Patel 2020 USA | A case study of COVID-19/HIV co-infection | The interest outcome was not reported |
28 | Guo 2020 China | A survey among COVID-19/HIV co-infected cases | The interest outcome was not reported |
29 | Shalev 2020 USA | 31 patients with COVID-19/HIV co-infection | The outcomes of interest were not reported |
30 | Karmen-Tuohy 2020 USA | A case control of 21 patients COVID-19/HIV co-infection | The outcomes of interest were not reported |
31 | Toombs 2020 United Kingdom | Three Cases with COVID-19/HIV co-infection | Do not contain the outcome of interest |
32 | Ruan 2020 China | Three cases with COVID-19/HIV co-infection | Had no outcome of interest reported |
33 | Sun 2020 Singapore | A case of SARS-2/HIV co-infection | Had no outcome of interest reported |
34 | Richardson 2020 USA | 43 cases of SARS-2/HIV co-infection | Do not contain the outcome of interest |
35 | Ho 2020 USA | 93 cases of SARS-s/HIV co-infection | The outcomes of interest were not reported |
36 | Su 2020 China | Two cases with SARS-2/AIDS co-infection | The outcomes of interest were not reported |
37 | Kumar India | A case of COVID-19/HIV co-infection | Had no outcome of interest reported |